Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematopoietic Stem Cell Therapy vs Standard of Care in Inflammatory Multiple Sclerosis
2012-004165-41Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Sep 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous peripheral blood stem cell transplantation in multiple sclerosis (MS), sponsored by Northwestern University. Started Sep 2013; status: completed.
02
Drugs
autologous peripheral blood stem cell transplantation
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-004165-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004165-41.